96.88
前日終値:
$96.60
開ける:
$96.45
24時間の取引高:
13.39M
Relative Volume:
1.47
時価総額:
$143.62B
収益:
$19.35B
当期純損益:
$2.78B
株価収益率:
51.82
EPS:
1.8696
ネットキャッシュフロー:
$3.82B
1週間 パフォーマンス:
-5.66%
1か月 パフォーマンス:
-3.02%
6か月 パフォーマンス:
-7.42%
1年 パフォーマンス:
+5.88%
Boston Scientific Corp Stock (BSX) Company Profile
名前
Boston Scientific Corp
セクター
電話
508-683-4000
住所
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
BSX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
BSX
Boston Scientific Corp
|
96.88 | 143.20B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
ABT
Abbott Laboratories
|
128.11 | 215.57B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
SYK
Stryker Corp
|
368.27 | 137.86B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.20 | 127.43B | 34.76B | 4.79B | 5.21B | 3.7049 |
|
EW
Edwards Lifesciences Corp
|
85.13 | 48.80B | 5.88B | 1.34B | 799.60M | 2.3489 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-03 | ダウングレード | Erste Group | Buy → Hold |
| 2025-09-08 | アップグレード | Oppenheimer | Perform → Outperform |
| 2025-06-16 | 開始されました | Leerink Partners | Outperform |
| 2025-04-16 | アップグレード | Needham | Hold → Buy |
| 2025-01-10 | アップグレード | Deutsche Bank | Hold → Buy |
| 2024-10-18 | ダウングレード | Needham | Buy → Hold |
| 2024-05-30 | 開始されました | Goldman | Buy |
| 2024-02-01 | アップグレード | Mizuho | Neutral → Buy |
| 2023-07-19 | 開始されました | Robert W. Baird | Outperform |
| 2023-06-30 | 開始されました | CL King | Buy |
| 2023-05-30 | 再開されました | Morgan Stanley | Overweight |
| 2023-03-29 | 開始されました | UBS | Buy |
| 2022-12-22 | 開始されました | Mizuho | Neutral |
| 2022-12-20 | 再開されました | Citigroup | Buy |
| 2022-10-18 | 開始されました | Barclays | Overweight |
| 2022-10-12 | 開始されました | Jefferies | Buy |
| 2022-07-06 | 開始されました | Wolfe Research | Outperform |
| 2022-05-27 | アップグレード | Needham | Hold → Buy |
| 2022-04-13 | 再開されました | Truist | Buy |
| 2022-03-02 | 再開されました | BofA Securities | Buy |
| 2021-12-10 | 開始されました | RBC Capital Mkts | Outperform |
| 2021-05-26 | ダウングレード | Needham | Buy → Hold |
| 2021-05-25 | 開始されました | Barclays | Overweight |
| 2021-04-15 | 開始されました | Atlantic Equities | Overweight |
| 2020-09-17 | 開始されました | Truist | Buy |
| 2020-09-11 | 開始されました | Wolfe Research | Peer Perform |
| 2020-04-22 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | アップグレード | Goldman | Neutral → Buy |
| 2020-03-05 | 開始されました | Citigroup | Buy |
| 2020-02-13 | 開始されました | Goldman | Neutral |
| 2020-02-06 | 再開されました | BTIG Research | Buy |
| 2019-12-30 | 繰り返されました | Cowen | Outperform |
| 2019-12-19 | ダウングレード | Needham | Strong Buy → Buy |
| 2019-09-05 | 再開されました | JP Morgan | Overweight |
| 2019-09-03 | 再開されました | Barclays | Overweight |
| 2019-05-13 | アップグレード | Evercore ISI | In-line → Outperform |
| 2018-11-28 | 開始されました | UBS | Buy |
| 2018-10-16 | 開始されました | Barclays | Overweight |
| 2018-10-02 | 繰り返されました | Morgan Stanley | Overweight |
| 2018-09-07 | 繰り返されました | Needham | Strong Buy |
| 2018-09-04 | アップグレード | Jefferies | Hold → Buy |
| 2018-07-06 | 繰り返されました | Needham | Strong Buy |
| 2018-06-27 | 開始されました | Bernstein | Outperform |
| 2018-04-26 | 繰り返されました | Needham | Strong Buy |
すべてを表示
Boston Scientific Corp (BSX) 最新ニュース
Analysts project durable growth with many near-term catalysts for Boston Scientific - MassDevice
BTIG Reiterates Boston Scientific (BSX) Buy Recommendation - Nasdaq
Internal Neuromodulation Devices Market Poised to Exceed USD 44.57 Billion by 2033 | Astute Analytica - GlobeNewswire Inc.
Can Boston Scientific Corporation stock sustain institutional flowsMarket Activity Report & AI Driven Stock Reports - newser.com
Will Boston Scientific Corporation stock benefit from automation - newser.com
Is Boston Scientific Corporation stock undervalued after correctionJuly 2025 Big Picture & Safe Entry Momentum Tips - newser.com
Boston Scientific (BSX) Announces 2026 Compensation Plans to Dri - GuruFocus
Boston Scientific, Epic collaborate on cardiac diagnostic EHR services - MassDevice
Boston Scientific Approves 2026 Bonus Plan - TipRanks
Boston Scientific Corp. Stock Outperforms Competitors Despite Losses On The Day - 富途牛牛
[8-K] BOSTON SCIENTIFIC CORP Reports Material Event | BSX SEC FilingForm 8-K - Stock Titan
Boston Scientific (BSX) Stock Today: Price Slips as Neuromodulation Bull Case, Epic EHR Deal and Big Fund Moves Shape the Outlook – November 19, 2025 - ts2.tech
Siemens partners with Boston Sci, eyes standalone growth - BioWorld MedTech
Using AI based signals to follow Boston Scientific Corporation2025 Performance Recap & Advanced Technical Analysis Signals - newser.com
Can Boston Scientific Corporation stock deliver consistent EPS growth2025 Sector Review & Daily Chart Pattern Signal Reports - newser.com
Does Boston Scientific Corporation stock trade at a discount to peersWeekly Volume Report & Entry and Exit Point Strategies - newser.com
Boston Scientific at Wolfe Conference: Innovation and Market Growth - Investing.com
Wall Street Analysts Believe Boston Scientific (BSX) Could Rally 25.34%: Here's is How to Trade - Finviz
Zacks Industry Outlook Highlights Boston Scientific, Insulet, BioLife Solutions and Allurion - Nasdaq
Can Boston Scientific Corporation recover in the next quarterNew Guidance & Free Accurate Trade Setup Notifications - newser.com
Why Boston Scientific Corporation stock is favored by hedge fundsWeekly Trade Report & Free High Accuracy Swing Entry Alerts - newser.com
2 Reasons to Watch BSX and 1 to Stay Cautious - Finviz
What earnings revisions data tells us about Boston Scientific Corporation2025 Retail Activity & Risk Controlled Daily Trade Plans - newser.com
Is Boston Scientific's Valuation Justified After 18% Gain and New Product Launches? - Yahoo Finance
What Boston Scientific (BSX)'s Surging Sales and Siemens Partnership Mean for Shareholders - Yahoo! Finance Canada
[Form 4] BOSTON SCIENTIFIC CORP Insider Trading Activity - Stock Titan
Boston Scientific Corp. stock underperforms Friday when compared to competitors - MarketWatch
Boston Scientific gains US distribution duties for Siemens Healthineers’ ICE catheter - Yahoo Finance
Boston Scientific Up 7% in a Month: How Should You Play the Stock? - Finviz
Can Boston Scientific Corporation stock test all time highsQuarterly Portfolio Report & Weekly High Conviction Ideas - newser.com
UBS Boosts Boston Scientific (BSX) Price Target After Strong Q3 Earnings - Insider Monkey
Boston Scientific, Siemens Healthineers ink 4D ICE catheter development deal - MassDevice
Boston Scientific enrolls first patient in AFib mapping study using OptiMap, Farapulse - MassDevice
Boston Scientific (BSX) Crossed Above the 200-Day Moving Average: What That Means for Investors - Yahoo Finance
Investors more bullish on Boston Scientific (NYSE:BSX) this week as stock grows 3.7%, despite earnings trending downwards over past five years - Yahoo Finance
CLOSURE-AF study not the end of the line for LAAC devices - BioWorld MedTech
Brokers Suggest Investing in Boston Scientific (BSX): Read This Before Placing a Bet - Yahoo Finance
If You Invested $1000 in Boston Scientific a Decade Ago, This is How Much It'd Be Worth Now - Yahoo Finance
Is Boston Scientific (BSX) a Solid Growth Stock? 3 Reasons to Think "Yes" - Yahoo Finance
Boston Scientific Corp (BSX) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):